Source: Endocrinology. Unidade: ICB
Subjects: FISIOLOGIA, PROLACTINA, OBESIDADE, DIABETES MELLITUS, RECEPTORES DE DOPAMINA, BROMO, INSULINA, GLICOSE, RESISTÊNCIA À INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURIGO, Isadora Clivatti et al. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice. Endocrinology, v. 160, n. 1, p. 193-204, 2019Tradução . . Disponível em: https://doi.org/10.1210/en.2018-00629. Acesso em: 25 ago. 2024.APA
Furigo, I. C., Suzuki, M. F., Oliveria, J. E. de, Lobo, A. M. R., Teixeira, P. D. S., Pedroso, J. A. B., et al. (2019). Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice. Endocrinology, 160( 1), 193-204. doi:10.1210/en.2018-00629NLM
Furigo IC, Suzuki MF, Oliveria JE de, Lobo AMR, Teixeira PDS, Pedroso JAB, Alencar A de, Zampieri TT, Buonfiglio D do C, Bergonsi PGFQ, Prada P de O, Bartolini P, Soares CRJ, Donato Junior J. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice [Internet]. Endocrinology. 2019 ; 160( 1): 193-204.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1210/en.2018-00629Vancouver
Furigo IC, Suzuki MF, Oliveria JE de, Lobo AMR, Teixeira PDS, Pedroso JAB, Alencar A de, Zampieri TT, Buonfiglio D do C, Bergonsi PGFQ, Prada P de O, Bartolini P, Soares CRJ, Donato Junior J. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice [Internet]. Endocrinology. 2019 ; 160( 1): 193-204.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1210/en.2018-00629